IOL Chemicals & Pharmaceuticals Ltd Share Price IOL Chemicals

185.35

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)

185.20

Open ()
Turnover (lac)
Prev. Close ()
Day's Vol.(shares)
Detailed Quote

Corporate Action

Period From
Period To
Purpose AGM Date Announcement Date Book Closure Start Date Book Closure End Date
Board Meeting - 20-May-2019 - -
IOL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2019 ,inter alia, to consider and approve The meeting of the Board of Directors is scheduled to be held on Wednesday, the 29 May 2019 inter-alia to consider and approve the audited financial results of the Company for the quarter and year ended 31 March 2019. Notice published in Financial Express Economic Times and Punjabi Jagran on 21 May 2019, regarding Board Meeting of the Company scheduled to be held on 29 May 2019. (As Per BSE Announcement Dated On 21/05/2019) Pursuant to Regulations 30 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you the Board of Directors in its meeting held on 29 May 2019 had approved the following: 1. Audited Financial Results for the Quarter and Financial year ended 31 March 2019. 2. Appointment of Parshotam & Associates (P&A), Charted Accountants, Ludhiana as GST Auditors of the Company. 3. The Board has noted the enhancement of existing manufacturing facilities of Ibuprofen from 10000 MT per annum to 12000 MT per annum and Iso Butyl Benzene from 9000 MT per annum to 12000 MT per annum in May 2019 at aggregate capex of Rs 12.10 crore which is met from internal accruals. Kindly note that the meeting of Board of Directors commenced at 03.00 P.M and concluded at 5:10 P.M. Pursuant to Regulations 30 and 33 and other applicable provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you the Board of Directors in its meeting held on 29 May 2019 had approved Audited Financial Results for the Quarter and Financial year ended 31 March 2019. We are enclosing herewith the following: 1. Audited Financial Results for the Quarter and Financial year ended 31 March 2019. 2. Unmodified Auditors Report on Financial Results for the Quarter and Financial year ended 31 March 2019. 3. Declaration on Auditors Report with Unmodified Opinion under Regulation 33(3)(d) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 4. Disclosure of related party transactions for the year ended 31 March 2019 under Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. (As Per BSE Announcement Dated 29.05.2019)
Board Meeting - 29-Mar-2019 - -
Outcome of the meeting of Independent Directors held on 29 March 2019
Board Meeting - 04-Feb-2019 - -
IOL CHEMICALS & PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2019 ,inter alia, to consider and approve issue of securities on preferential basis to the promoters and the un-audited financial results of the Company for the quarter and nine months ended 31 December 2018. This is to inform you that the meeting of the Board of Directors is scheduled to be held on Tuesday, the 12 February 2019 inter-alia to consider issue of securities on preferential basis to the promoters and the un-audited financial results of the Company for the quarter and nine months ended 31 December 2018. Further, in terms of provisions of the Companys Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the Trading Window of the Company shall remain closed with immediate effect and will open after 48 hours, the financial results for the quarter and nine months ended 31 December 2018 made public. Dear Sir, Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on 12 February 2019 has approved the following: 1. Un-audited Financial Results for the Quarter and nine months ended 31 December 2018. 2. Appointment of Mr Rajender Mohan Malla, Independent Director as Chairman of the Board. 3. Re-appointment of Mr Vijay Garg, as Joint Managing Director of the company. 4. Modifications in the Code of Conduct to Regulate, Monitor and Report Trading by Insiders which will take effect from 1 April 2019. 5. Issue of 25,00,000 (Twenty five lakh) convertible warrants on preferential basis to M/s Towel Enterprises Limited, Promoter company at a price of Rs. 205/- per warrant being the price not less than the price determined in accordance with the SEBI (Issue of Capital and Disclosure Requirements) Regulations 2018, carrying an option to the holder of such warrants to subscribe to one equity share of Rs. 10/- for every warrant held, within 18 months from the date of allotment of the warrants. 6. Reclassification of the Authorised Share Capital of the Company from Rs. 80,00,00,000/- (Rupees eighty crore) divided into 2,20,00,000 (Two crore twenty lakh) Preference Shares of Rs. 10/- (Rupees ten) each and 5,80,00,000 (Five crore eighty lakh) Equity Shares of Rs. 10/- (Rupees ten) each to Rs. 80,00,00,000/- (Rupees eighty crore) divided into 8,00,00,000 (Eight crore) Equity Shares of Rs. 10/- (Rupees ten) each. 7. Convening of Extra-ordinary General Meeting of the shareholders on Wednesday, 13 March 2019 at 11:00 a.m. at registered office situated at Trident Complex, Raikot Road, Barnala, Punjab. The details as required under the SEBI LODR read with SEBI Circular No. CIR/CFD/CMD/4/2015 dated September 9, 2015 with respect to the proposed preferential issue are given in Annexure A. The meeting of Board of Directors commenced at 12:00 NOON and concluded at 3:40 PM This is for your information & record please. (As Per BSE Announcement Dated 12.02.2019)
Board Meeting - 05-Nov-2018 - -
IOL CHEMICALS has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2018 ,inter alia, to consider and approve This is to inform you that the meeting of the Board of Directors is scheduled to be held on Wednesday, the 14 November 2018 inter-alia to consider and approve the un-audited financial results of the Company for the quarter and half year ended 30 September 2018. Further, in terms of provisions of the Companys Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the Trading Window of the Company shall remain closed from 06 November 2018 and will open after 48 hours, the financial results for the quarter and half year ended 30 September 2018 made public. In terms of provisions of the Companys Code of Conduct to Regulate, Monitor and Report Trading by Insiders, the Trading Window of the Company shall remain closed from 06 November 2018 and will open after 48 hours, the financial results for the quarter and half year ended 30 September 2018 made public. Copy of Notice published in Newspapers (As Per BSE Announcement Dated On 06/11/2018) Pursuant to Regulations 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing un-audited Financial Results for the Quarter and half year ended 30 September 2018 as approved by the Board of Directors in its meeting held on 14 November 2018 (12.00 Noon to 3:40 PM) along with Limited Review Report on the Un-audited Financial Results by M/s Ashwani & Associates, Statutory Auditors of the company. The same is also available on the website of the Company i.e. www.iolcp.com. Pursuant to Regulations 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish to inform you that the Board of Directors in its meeting held on 14 November 2018 has approved the following: 1. Appointment of Mr Varinder Gupta, Managing Director as Chairman of the company. 2. The Board condoled untimely and sad demise of Dr M A Zahir, Chairman of the Company. The Board had conveyed its heartfelt condolences to the bereaved family on behalf of the company. The Board placed on record his invaluable contribution to the progress of the company. 3. Un-audited Financial Results for the Quarter and half year ended 30 September 2018. 4. Enhancement of existing manufacturing facilities of Metformin (Unit IV) from 3,000 TPA to 4,000 TPA in Pharma segment. The additional manufacturing facility of Metformin has been installed with capex of 2.71 crore. The project cost has been funded through internal accruals. 5. Completion of Unit V to manufacture Clopidogrel Bisulphate and Fenofibrate with capacity of 180 TPA with capex of 19.26 crore. The project cost has been funded through internal accruals. 6. Confirmed resolution passed by circulation confirming the reconstitution of Audit and Risk Management Committee consisting of Dr Sandhya Mehta, Independent Director as Chairman, Mr Chandra Mohan, Independent Director and Mr Vikas Gupta, Executive Director. 7. Approved the Corporate Social Responsibility Policy, a copy of which is being placed on website of the company. The meeting of Board of Directors commenced at 12:00 noon and concluded at 3:40 p.m. (As Per BSE Announcement Dated On 14/11/2018)
Board Meeting - 31-Jul-2018 - -
Quarterly Results IOL CHEMICALS has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2018 ,inter alias, to consider and approve un-audited financial results of the Company for the quarter ended 30 June 2018 Outcome of the Board meeting (As Per BSE Announcement Dated On 11/08/2018)